June 25, 2012
Otsuka Pharmaceutical and UCB Japan announced on June 21 that they have applied for the antiepileptic drug E Keppra Tablet 250 mg and 500 mg (levetiracetam) for adjunctive therapy in combination with other antiepileptic drugs in the treatment of the...read more